Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K231930
    Date Cleared
    2024-03-22

    (266 days)

    Product Code
    Regulation Number
    892.1550
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K102991, K151339, K170085

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Digital Ultrasonic Diagnostic Imaging System (Model: F6) is a general use ultrasound device intended for use by appropriately qualified and trained healthcare professionals for ultrasound imaging, measurement, display and fluid flow analysis of the human body. Specific clinical applications and exam types include: Abdominal, Obstetrics, Gynaecology, Small Parts (breast, thyroid, etc.), Peripheral Vascular, Urology. Modes of operation include B mode, M mode, Color Doppler, Power Doppler, PWD and Combined (B+M; B+CD; B+PWD). This system is suitable for use in hospital and clinical settings.

    Device Description

    The Digital Ultrasonic Diagnostic Imaging System is designed to be portable notebook ultrasound systems and mainly include the ultrasound equipment, transducer and adapter. The equipment to complete the ultrasonic imaging function, host completes the image display, measurement, patient information, image storage, and other applications Standard keyboards, touch panels, and buttons, as well as multifunctional editors, mainly control device operations. The display screen is used to display work interfaces, images, and parameters. Different interfaces are used to connect transducers, other devices, or power supplies. There are four different types of transducers, namely large convex, linear array, Micro convex, Intracavity, the frequency scope of different transducers is from 2.5MHz to 11MHz. The system provides a variety of modes for flexibly selecting, which include B-mode, M-mode, Color-mode, Power-mode, PW-mode, and combined modes (i.e., B/M- mode). Real time image and dynamic changes of tissues, organs or vessels will be showed in the image under B-mode, while coloring blood flow can be seen under Color-mode, PW-mode or Power-mode. M-mode is defined as time motion display of the ultrasound wave along a chosen ultrasound line. The system not only provides real-time tissues, organs or blood flow images, but also contains measurement of anatomical structures and analysis packages, which can offer diagnosticians detailed and useful information.

    AI/ML Overview

    The provided document is a 510(k) Premarket Notification from the FDA for a Digital Ultrasonic Diagnostic Imaging System (Model: F6). This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving the device meets specific acceptance criteria through a dedicated study with performance metrics.

    Therefore, the document does not contain the detailed information requested regarding acceptance criteria and a study proving the device meets them in the way a clinical trial or performance study report would.

    However, based on the information provided, here's what can be extracted and inferred:

    1. A table of acceptance criteria and the reported device performance

    The document doesn't present a formal table of acceptance criteria and reported device performance. Instead, it relies on demonstrating substantial equivalence to predicate devices, implying that the acceptance criteria are met if the device's technical characteristics and performance are comparable or don't raise new safety/effectiveness concerns.

    The "Test Summary" section (6.1 Summary of Non-Clinical Tests) lists various international and FDA guidance standards that the device has been evaluated against. Meeting these standards is an implicit "acceptance criterion" for safety, electromagnetic compatibility, and basic performance.

    Acceptance Criteria (Inferred from Standards)Reported Device Performance
    Safety and Essential Performance:
    IEC 60601-1 Ed 3.2 2020-08 (General requirements for basic safety and essential performance)Evaluated and presumably met
    IEC 60601-1-2 Ed 4.1 2020-09 (Electromagnetic disturbances)Evaluated and presumably met
    IEC 60601-2-37 Ed 2.1 2015 (Ultrasonic medical diagnostic and monitoring equipment)Evaluated and presumably met
    IEC 62133-2 Ed 1.0 2017-02 (Safety requirements for lithium systems)Evaluated and presumably met
    Biocompatibility:
    ISO 10993-5 2009-06-01 (Tests for in vitro cytotoxicity)Evaluated and presumably met
    ISO 10993-10 2021-11 (Tests for skin sensitization)Evaluated and presumably met
    ISO 10993-23 2021-01 (Tests for irritation)Evaluated and presumably met
    Acoustic Output:
    FDA Guidance: "Marketing Clearance of Diagnostic Ultrasound Systems and Transducers" (Feb 21, 2023) - Track 3SPTA max=720 mw/cm², MI max =1.9, MI display, TI display (These values are the performance and are compared to the predicate's values)
    Software Functions:
    FDA Guidance: "Content of Premarket Submissions for Device Software Functions" (June 14, 2023)Evaluated and presumably met
    Clinical Accuracy Performance:
    FDA Guidance: "Marketing Clearance of Diagnostic Ultrasound Systems and Transducers" (Feb 21, 2023) - Clinical accuracy performanceEvaluated and presumably met via non-clinical tests (as no clinical study was included)

    2. Sample sized used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

    The document explicitly states: "No clinical study is included in this submission." Therefore, there is no information about a test set sample size or its provenance in terms of patient data. The "tests" mentioned are non-clinical (bench testing) against standards.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

    Since there was no clinical study, there is no mention of experts establishing ground truth for a test set.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable as there was no clinical test set.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    Not applicable. The device is a "Digital Ultrasonic Diagnostic Imaging System," which is a standalone imaging device, not an AI-assisted diagnostic tool that would involve human readers and comparative effectiveness studies.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    This question typically applies to AI/software as a medical device. The device in question is a diagnostic ultrasound system. Its performance is assessed through its ability to generate images, measure, display, and analyze fluid flow, which is its inherent standalone function. The non-clinical tests listed serve to prove its performance in this standalone capacity by meeting established safety and performance standards relevant to ultrasound technology.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    For the non-clinical tests, the "ground truth" would be the specifications and requirements outlined in the referenced standards (e.g., specific acoustic output limits, cytotoxicity thresholds, electromagnetic compatibility levels).

    8. The sample size for the training set

    Not applicable. This device is a diagnostic ultrasound system, not an AI/machine learning model that typically requires a training set of data.

    9. How the ground truth for the training set was established

    Not applicable, as it's not an AI/ML device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1